Catalent Inc
NYSE:CTLT
Catalent Inc
NYSE:CTLT
Price:
55.95 USD
-0.14%
Market Closed
Updated:
Apr 25, 2024
Catalent Inc
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
Catalent Inc
Revenue Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Catalent Inc
NYSE:CTLT
|
Revenue
$4.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Catalent Inc
Revenue Breakdown
Breakdown by Geography
Catalent Inc
Catalent Inc
|
Total Revenue:
4.3B
USD
|
|
United States:
2.8B
USD
|
|
Europe:
1.3B
USD
|
|
International Other:
355m
USD
|
Breakdown by Segments
Catalent Inc
Catalent Inc
|
Total Revenue:
4.3B
USD
|
|
Development Services:
2.4B
USD
|
|
Manufacturing & Commercial Product Supply:
1.9B
USD
|
See Also
What is Catalent Inc's Revenue?
Revenue
4.1B
USD
4.1B
USD
Based on the financial report for Dec 31, 2023, Catalent Inc's Revenue amounts to 4.1B USD.
What is Catalent Inc's Revenue growth rate?
Revenue CAGR 10Y
9%
9%
Over the last year, the Revenue growth was -13%. The average annual Revenue growth rates for Catalent Inc have been 6% over the past three years , 10% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
